Canada Pension Plan Investment Board
TERN

Canada Pension Plan Investment Board’s Terns Pharmaceuticals TERN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,600
Closed -$1.19M – 1862
2026
Q1 		$1.19M Sell
22,600
-122,200
-84% -$5.02M ﹤0.01% 982
2025
Q4 		$5.85M Buy
144,800
+143,400
+10,243% +$3.31M ﹤0.01% 749
2025
Q3 		$10.5K Sell
1,400
-10,900
-89% -$69.6K ﹤0.01% 1322
2025
Q2 		$45.9K Buy
+12,300
New +$38.4K ﹤0.01% 1262

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Canada Pension Plan Investment Board's TERN Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 22,600 shares — an estimated $1.19M sold.

Canada Pension Plan Investment Board first reported a position in TERN in Q2 2025 and held it in 4 quarters. The position peaked at $5.85M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 22,600 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.19M.
  • Canada Pension Plan Investment Board first reported a position in Terns Pharmaceuticals in Q2 2025 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Terns Pharmaceuticals position peaked at $5.85M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.